Curis (CRIS) EBITDA Margin (2010 - 2025)

Curis (CRIS) reported EBITDA Margin of 1700.88% for Q4 2025, up 198841.0% on a YoY basis from N/an in Q4 2024, and up 798.92% quarter-over-quarter from 243.36% in Q3 2025.

Curis (CRIS) EBITDA Margin (2010 - 2025) Analysis & Trends

Curis has reported EBITDA Margin for 16 years, with the latest figure at 1700.88% in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 198841.0% year-over-year to 1700.88%; the trailing twelve-month figure through Mar 2026 stood at 299.66% (up 7944.0% YoY), and the FY2025 full-year result was 80.29%, up 31958.0% from the prior year.
  • EBITDA Margin for Q4 2025 stood at 1700.88%, up from 243.36% in the prior quarter.
  • The five-year high for EBITDA Margin was 1700.88% in Q4 2025, with the low at 799.76% in Q1 2022.
  • Historically, EBITDA Margin has averaged 345.94% across 5 years, with a median of 441.94% in 2021.
  • Annual changes were most pronounced in 2022 — EBITDA Margin slumped 34599 bps — and 2025, when it jumped 198841 bps.
  • Curis' EBITDA Margin stood at 437.83% in 2021, then grew by 13 bps to 382.27% in 2022, then declined by 12 bps to 429.75% in 2023, then surged by 33 bps to 287.53% in 2024, then surged by 692 bps to 1700.88% in 2025.
  • The last three EBITDA Margin figures came in at 1700.88% (Q4 2025), 243.36% (Q3 2025), and 312.59% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 38.10%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Curis 8.58 Mn -6.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,700.88%
Sep 30, 2025 -243.36%
Jun 30, 2025 -312.59%
Mar 31, 2025 -446.05%
Dec 31, 2024 -287.53%
Sep 30, 2024 -345.75%
Jun 30, 2024 -475.22%
Mar 31, 2024 -564.09%
Dec 31, 2023 -429.75%
Sep 30, 2023 -426.40%
Jun 30, 2023 -544.74%
Mar 31, 2023 -494.73%
Dec 31, 2022 -382.27%
Sep 30, 2022 -467.89%
Jun 30, 2022 -670.46%
Mar 31, 2022 -799.76%
Dec 31, 2021 -437.83%
Sep 30, 2021 -363.64%
Jun 30, 2021 -473.84%
Mar 31, 2021 -453.77%